Özlem Özmen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Özlem Özmen has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Ebru Tatcı
University of Health Sciences Türkiye, Ankara Etlik City Hospital, Clinic of Nuclear Medicine, Ankara, Türkiye
8 shared publications - Funda Demirag
SBU, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pathology, Ankara, Turkey
8 shared publications - Nur Aydinbelge Dizdar
Ankara Etlik City hospital
6 shared publications - Atila Gökçek
Department of Radiology, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey
4 shared publications Ebru Tatci
Nuclear Medicine
4 shared publications- Pınar Akın Kabalak
Department of Chest Disease, Ankara Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Ankara, Turkey
4 shared publications
Latest Publications
- 9 November 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
Low-level Radioactive Contamination Detected by a High-sensitivity Cadmium-Zinc-Telluride SPECT System Despite Background-level Survey Measurements
A 76-year-old woman underwent myocardial perfusion Single Photon Emission Computed Tomography (SPECT) using a high-sensitivity cadmium-zinc-telluride camera after administration of 8 mCi 99m Tc Methoxyisobutylisonitrile (MIBI). An unexpected diffuse peripheral count distribution was observed. No specific contamination event was identified, and surveys of the detector surface and patient table remained at background levels. Persistent counts on source-free blank imaging despite decontamination initially suggested a possible technical issue. However, serial blank acquisitions demonstrated progressive count reduction consistent with 99m Tc physical decay, supporting low-level residual 99m Tc contamination. This case demonstrates that high-sensitivity cadmium-zinc-telluride systems may detect low-level contamination not identified by conventional survey measurements.
- 9 November 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
Low-level Radioactive Contamination Detected by a High-sensitivity Cadmium-Zinc-Telluride SPECT System Despite Background-level Survey Measurements
A 76-year-old woman underwent myocardial perfusion Single Photon Emission Computed Tomography (SPECT) using a high-sensitivity cadmium-zinc-telluride camera after administration of 8 mCi 99m Tc Methoxyisobutylisonitrile (MIBI). An unexpected diffuse peripheral count distribution was observed. No specific contamination event was identified, and surveys of the detector surface and patient table remained at background levels. Persistent counts on source-free blank imaging despite decontamination initially suggested a possible technical issue. However, serial blank acquisitions demonstrated progressive count reduction consistent with 99m Tc physical decay, supporting low-level residual 99m Tc contamination. This case demonstrates that high-sensitivity cadmium-zinc-telluride systems may detect low-level contamination not identified by conventional survey measurements.
- 10 September 2026
- Published by Springer Nature in Clinical and Translational Oncology
- p. 1-7
Baseline fdg pet/ct-derived tumor burden and host metabolic activity predict complete metabolic response to neoadjuvant chemotherapy in ınvasive ductal breast cancer
Purpose To evaluate the prognostic significance of FDG PET/CT-derived tumor burden, host metabolic activity, inflammatory biomarkers, and body composition parameters for predicting complete metabolic response (CMR) following neoadjuvant chemotherapy (NAC) in patients with invasive ductal breast cancer. Materials and methods Ninety women with histologically confirmed invasive ductal breast cancer who underwent baseline and post-treatment FDG PET/CT examinations following NAC were retrospectively included. Metabolic tumor volume (MTV), total lesion glycolysis (TLG), brain-to-liver ratio (Brain/LR), bone marrow-to-liver ratio (BM/LR), neutrophil-to-lymphocyte ratio (NLR), and psoas muscle-to-subcutaneous fat thickness ratio (PS/SCFT) were analyzed. Correlation analyses, multivariable regression analyses, and ROC analyses were performed. Results CMR was achieved in 77 patients (85.6%), whereas 13 patients (14.4%) demonstrated residual metabolic disease. Baseline MTV and TLG were significantly higher in non-CMR patients (p=0.024 and p = 0.004, respectively). Brain/LR was significantly lower in non-responders (p = 0.007). Ki-67 demonstrated a significant inverse correlation with MTV (ρ = − 0.309, p = 0.003). In multivariable regression analysis, baseline BM/LR (β = 0.363, p = 0.017) and baseline PS/SCFT (β = − 0.268, p = 0.017) independently predicted post-treatment SUVmax. ROC analysis demonstrated AUC values of 0.705 for MTV, 0.757 for TLG, 0.734 for Brain/LR, and 0.864 for the combined predictive model. Conclusion Baseline volumetric tumor burden is strongly associated with metabolic response following NAC. Integration of tumor burden parameters with host metabolic and body composition biomarkers may improve individualized treatment-response prediction in breast cancer.
- 10 September 2026
- Published by Springer Nature in Clinical and Translational Oncology
- p. 1-7
Baseline fdg pet/ct-derived tumor burden and host metabolic activity predict complete metabolic response to neoadjuvant chemotherapy in ınvasive ductal breast cancer
Purpose To evaluate the prognostic significance of FDG PET/CT-derived tumor burden, host metabolic activity, inflammatory biomarkers, and body composition parameters for predicting complete metabolic response (CMR) following neoadjuvant chemotherapy (NAC) in patients with invasive ductal breast cancer. Materials and methods Ninety women with histologically confirmed invasive ductal breast cancer who underwent baseline and post-treatment FDG PET/CT examinations following NAC were retrospectively included. Metabolic tumor volume (MTV), total lesion glycolysis (TLG), brain-to-liver ratio (Brain/LR), bone marrow-to-liver ratio (BM/LR), neutrophil-to-lymphocyte ratio (NLR), and psoas muscle-to-subcutaneous fat thickness ratio (PS/SCFT) were analyzed. Correlation analyses, multivariable regression analyses, and ROC analyses were performed. Results CMR was achieved in 77 patients (85.6%), whereas 13 patients (14.4%) demonstrated residual metabolic disease. Baseline MTV and TLG were significantly higher in non-CMR patients (p=0.024 and p = 0.004, respectively). Brain/LR was significantly lower in non-responders (p = 0.007). Ki-67 demonstrated a significant inverse correlation with MTV (ρ = − 0.309, p = 0.003). In multivariable regression analysis, baseline BM/LR (β = 0.363, p = 0.017) and baseline PS/SCFT (β = − 0.268, p = 0.017) independently predicted post-treatment SUVmax. ROC analysis demonstrated AUC values of 0.705 for MTV, 0.757 for TLG, 0.734 for Brain/LR, and 0.864 for the combined predictive model. Conclusion Baseline volumetric tumor burden is strongly associated with metabolic response following NAC. Integration of tumor burden parameters with host metabolic and body composition biomarkers may improve individualized treatment-response prediction in breast cancer.
- Open Access
- 26 August 2026
- Published by Akdema Bilisim Yayincilik ve Dan. Tic. Ltd. Sti (Publications) in Radiation Sciences in Oncology
- Vol. 1 (2) , 59-69
Associations of psoas muscle index and inflammatory markers with FDG PET/CT-derived metabolic response after total neoadjuvant therapy in locally advanced rectal cancer
Objective: Total neoadjuvant therapy (TNT) is increasingly used for locally advanced rectal cancer, but factors associated with metabolic tumor response remain unclear. This study aimed to explore correlations between fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT)-derived metabolic tumor response and patient-related factors, including body composition, systemic inflammatory markers, and imaging-based biomarkers, in patients receiving TNT. Materials and Methods: This retrospective single-center study included 15 patients with locally advanced rectal cancer who underwent baseline and post-treatment FDG PET/CT imaging. Metabolic tumor parameters, including maximum standardized uptake value (SUVmax), standardized uptake value normalized to lean body mass mean (SULmean), total lesion glycolysis (TLG), and metabolic tumor volume (MTV), were extracted, and percentage changes were calculated. Psoas muscle area, psoas muscle index (PMI), and subcutaneous fat were measured from the CT component, while spleen-to-liver ratio (SLR), liver-to-rectus femoris ratio (LRF), and laboratory inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), albumin, and C-reactive protein (CRP), were assessed as host-related variables. Results: Significant reductions were observed in all metabolic PET/CT parameters after treatment. Psoas muscle area and PMI showed significant negative correlations with percentage changes in all four metabolic parameters, with correlation coefficients ranging from −0.614 to −0.879, suggesting that higher psoas-derived muscle measurements may be associated with greater metabolic reduction after treatment. Albumin change was significantly correlated with TLG and MTV response. In contrast, NLR, PLR, CRP, and subcutaneous fat showed no significant associations with metabolic tumor response. The SLR correlated modestly with MTV change only. Conclusion: Baseline psoas-derived muscle measurements, particularly PMI, may be associated with metabolic tumor response after TNT in locally advanced rectal cancer. These findings should be considered preliminary and hypothesis-generating and may support further evaluation of body composition assessment during pre-treatment evaluation of this patient population.
- 26 August 2026
- Published by Akdema Bilisim Yayincilik ve Dan. Tic. Ltd. Sti (Publications) in Radiation Sciences in Oncology
- Vol. 1 (2) , 59-69
Open AccessAssociations of psoas muscle index and inflammatory markers with FDG PET/CT-derived metabolic response after total neoadjuvant therapy in locally advanced rectal cancer
Objective: Total neoadjuvant therapy (TNT) is increasingly used for locally advanced rectal cancer, but factors associated with metabolic tumor response remain unclear. This study aimed to explore correlations between fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT)-derived metabolic tumor response and patient-related factors, including body composition, systemic inflammatory markers, and imaging-based biomarkers, in patients receiving TNT. Materials and Methods: This retrospective single-center study included 15 patients with locally advanced rectal cancer who underwent baseline and post-treatment FDG PET/CT imaging. Metabolic tumor parameters, including maximum standardized uptake value (SUVmax), standardized uptake value normalized to lean body mass mean (SULmean), total lesion glycolysis (TLG), and metabolic tumor volume (MTV), were extracted, and percentage changes were calculated. Psoas muscle area, psoas muscle index (PMI), and subcutaneous fat were measured from the CT component, while spleen-to-liver ratio (SLR), liver-to-rectus femoris ratio (LRF), and laboratory inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), albumin, and C-reactive protein (CRP), were assessed as host-related variables. Results: Significant reductions were observed in all metabolic PET/CT parameters after treatment. Psoas muscle area and PMI showed significant negative correlations with percentage changes in all four metabolic parameters, with correlation coefficients ranging from −0.614 to −0.879, suggesting that higher psoas-derived muscle measurements may be associated with greater metabolic reduction after treatment. Albumin change was significantly correlated with TLG and MTV response. In contrast, NLR, PLR, CRP, and subcutaneous fat showed no significant associations with metabolic tumor response. The SLR correlated modestly with MTV change only. Conclusion: Baseline psoas-derived muscle measurements, particularly PMI, may be associated with metabolic tumor response after TNT in locally advanced rectal cancer. These findings should be considered preliminary and hypothesis-generating and may support further evaluation of body composition assessment during pre-treatment evaluation of this patient population.
- 21 August 2026
- Published by Springer Nature in Indian Journal of Surgery
- p. 1-11
Pulmonary Sarcomatoid Carcinoma: Updated Analysis on Prognostic Factors Influencing Diagnosis and Survival
- 21 August 2026
- Published by Springer Nature in Indian Journal of Surgery
- p. 1-11
Pulmonary Sarcomatoid Carcinoma: Updated Analysis on Prognostic Factors Influencing Diagnosis and Survival
- 20 August 2026
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 4 (3) , 79-87
The prognostic value of PET/CT-derived volumetric parameters for postoperative recurrence in resected non-small cell lung cancer
Aims: Non-small-cell lung cancer (NSCLC) recurrence is high even after complete surgical resection. This study aimed to investigate the relationship between recurrence and 18F-fluorodeoxyglucose positron emission tomography computed tomography parameters and to determine prognostic factors. Methods: Stage I–II NSCLC, confirmed through pathology after undergoing surgical resection were retrospective analyzed. Before surgery, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were derived by applying SUVmax-based thresholds of 2.5 and 42%. Data regarding demographics, clinicopathological features, and tumor characteristics were gathered. Kaplan–Meier method was used for disease-free survival (DFS) and overall survival rates. Prognostic factors causing recurrence were evaluated using univariate and multivariate Cox regression analysis. Results: The average age of the 179 people included in the study was 61.24 years. Median follow up time was 50 months. Recurrence occurred in 38.5% of the patients. Prognostic factors for recurrence were larger tumor size, visceral pleural invasion, and PL2 involvement. When stratified by histology, MTV measured using SUVmax thresholds of 2.5 and 42% was significantly higher in patients with recurrence in the squamous cell carcinoma subgroup. In univariate analysis, high MTV42% was associated with shorter DFS. In multivariate analysis, MTV2.5 remained an independent predictor of DFS. SUVmax and TLG were not independently associated with DFS. Conclusion: Disease-free survival was influenced by tumor size and the presence of pleural invasion. MTV may serve as a complementary prognostic biomarker to TNM staging in patients with early-stage NSCLC.
- 20 August 2026
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 4 (3) , 79-87
The prognostic value of PET/CT-derived volumetric parameters for postoperative recurrence in resected non-small cell lung cancer
Aims: Non-small-cell lung cancer (NSCLC) recurrence is high even after complete surgical resection. This study aimed to investigate the relationship between recurrence and 18F-fluorodeoxyglucose positron emission tomography computed tomography parameters and to determine prognostic factors. Methods: Stage I–II NSCLC, confirmed through pathology after undergoing surgical resection were retrospective analyzed. Before surgery, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were derived by applying SUVmax-based thresholds of 2.5 and 42%. Data regarding demographics, clinicopathological features, and tumor characteristics were gathered. Kaplan–Meier method was used for disease-free survival (DFS) and overall survival rates. Prognostic factors causing recurrence were evaluated using univariate and multivariate Cox regression analysis. Results: The average age of the 179 people included in the study was 61.24 years. Median follow up time was 50 months. Recurrence occurred in 38.5% of the patients. Prognostic factors for recurrence were larger tumor size, visceral pleural invasion, and PL2 involvement. When stratified by histology, MTV measured using SUVmax thresholds of 2.5 and 42% was significantly higher in patients with recurrence in the squamous cell carcinoma subgroup. In univariate analysis, high MTV42% was associated with shorter DFS. In multivariate analysis, MTV2.5 remained an independent predictor of DFS. SUVmax and TLG were not independently associated with DFS. Conclusion: Disease-free survival was influenced by tumor size and the presence of pleural invasion. MTV may serve as a complementary prognostic biomarker to TNM staging in patients with early-stage NSCLC.
- 18 August 2026
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
Tumor spread through air spaces in non-small-cell lung cancer: 18F-fluorodeoxyglucose PET-based tumoral and peritumoral radiomics analysis with machine learning
Objective: To investigate the utility of tumoral and peritumoral [ 18 F]-fluorodeoxyglucose PET-based radiomics models for predicting tumor spread through air spaces (STAS) in non-small-cell lung cancer (NSCLC). Methods: A total of 104 patients with NSCLC were retrospectively included and classified as STAS-positive or STAS-negative according to postoperative histopathology. Three radiomics models were developed based on tumoral and peritumoral volumes of interest (VOIs). Peritumoral models were constructed by defining VOIs with 5 and 10 mm expansions from the tumor margin (PR-5 and PR-10). Conventional PET-derived parameters were calculated. Each group was randomly divided into training (70%) and testing (30%) sets. For prediction, five machine learning algorithms were applied. Model performance was assessed by area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, and F1 score. Results: Of the 104 patients, 60 (57.7%) were in the STAS-positive group, and 44 (42.3%) were in the STAS-negative group. Statistically significant differences were found in 27 tumoral, 62 PR-5, and 89 PR-10 radiomic features between the groups. Support Vector Machine achieved the best performance for the tumoral model (AUC: 0.70), whereas Logistic Regression was optimal for the PR-5 and PR-10 models, with AUCs of 0.79 and 0.74, respectively. The mean F1 score values for the tumoral, PR-5, and PR-10 models were 0.67, 0.72, and 0.68, respectively. Maximum standardized uptake value (SUV max ), SUV mean , and SUV peak did not differ significantly between groups. Tumor size, total lesion glycolysis, and metabolic tumor volume were significantly higher in the STAS-positive group. Conclusion: Our findings suggest that peritumoral PET-based radiomics may help predict STAS status in NSCLC. The PR-5 model demonstrated the highest predictive performance, while conventional SUV-based parameters showed limited predictive value.
- 18 August 2026
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
Tumor spread through air spaces in non-small-cell lung cancer: 18F-fluorodeoxyglucose PET-based tumoral and peritumoral radiomics analysis with machine learning
Objective: To investigate the utility of tumoral and peritumoral [ 18 F]-fluorodeoxyglucose PET-based radiomics models for predicting tumor spread through air spaces (STAS) in non-small-cell lung cancer (NSCLC). Methods: A total of 104 patients with NSCLC were retrospectively included and classified as STAS-positive or STAS-negative according to postoperative histopathology. Three radiomics models were developed based on tumoral and peritumoral volumes of interest (VOIs). Peritumoral models were constructed by defining VOIs with 5 and 10 mm expansions from the tumor margin (PR-5 and PR-10). Conventional PET-derived parameters were calculated. Each group was randomly divided into training (70%) and testing (30%) sets. For prediction, five machine learning algorithms were applied. Model performance was assessed by area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, and F1 score. Results: Of the 104 patients, 60 (57.7%) were in the STAS-positive group, and 44 (42.3%) were in the STAS-negative group. Statistically significant differences were found in 27 tumoral, 62 PR-5, and 89 PR-10 radiomic features between the groups. Support Vector Machine achieved the best performance for the tumoral model (AUC: 0.70), whereas Logistic Regression was optimal for the PR-5 and PR-10 models, with AUCs of 0.79 and 0.74, respectively. The mean F1 score values for the tumoral, PR-5, and PR-10 models were 0.67, 0.72, and 0.68, respectively. Maximum standardized uptake value (SUV max ), SUV mean , and SUV peak did not differ significantly between groups. Tumor size, total lesion glycolysis, and metabolic tumor volume were significantly higher in the STAS-positive group. Conclusion: Our findings suggest that peritumoral PET-based radiomics may help predict STAS status in NSCLC. The PR-5 model demonstrated the highest predictive performance, while conventional SUV-based parameters showed limited predictive value.
- 4 February 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (2)
Lipoid proteinosis mimicking Sjögren’s syndrome: a diagnostic challenge in rheumatology practice
- 4 February 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (2)
Lipoid proteinosis mimicking Sjögren’s syndrome: a diagnostic challenge in rheumatology practice
- Open Access
- 26 December 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 64-66
A Rare Case of Small Cell Lung Carcinoma Diagnosed with a Breast Mass
A Rare Case of Small Cell Lung Carcinoma Diagnosed with a Breast Mass - Molecular Imaging and Radionuclide Therapy
- 26 December 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 64-66
Open AccessA Rare Case of Small Cell Lung Carcinoma Diagnosed with a Breast Mass
A Rare Case of Small Cell Lung Carcinoma Diagnosed with a Breast Mass - Molecular Imaging and Radionuclide Therapy
- Open Access
- 26 November 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 67-69
https://mirt.tsnmjournals.org/articles/metastatic-prostate-cancer-with-pulmonary-involvement-mimicking-pneumonia-findings-on-lesssupgreater18lesssupgreaterf-fdg-petct-and-lesssupgreater68lesssupgreaterga-psma-petct/doi/mirt.galenos.2025.79053
Metastatic Prostate Cancer with Pulmonary Involvement Mimicking Pneumonia: Findings on 18F-FDG PET/CT and 68Ga-PSMA PET/CT - Molecular Imaging and Radionuclide Therapy
- 26 November 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 67-69
Open Accesshttps://mirt.tsnmjournals.org/articles/metastatic-prostate-cancer-with-pulmonary-involvement-mimicking-pneumonia-findings-on-lesssupgreater18lesssupgreaterf-fdg-petct-and-lesssupgreater68lesssupgreaterga-psma-petct/doi/mirt.galenos.2025.79053
Metastatic Prostate Cancer with Pulmonary Involvement Mimicking Pneumonia: Findings on 18F-FDG PET/CT and 68Ga-PSMA PET/CT - Molecular Imaging and Radionuclide Therapy
- Open Access
- 11 November 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 55-57
Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by 18F-FDG PET/CT
Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by 18F-FDG PET/CT - Molecular Imaging and Radionuclide Therapy
- 11 November 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 55-57
Open AccessIsolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by 18F-FDG PET/CT
Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by 18F-FDG PET/CT - Molecular Imaging and Radionuclide Therapy